Healthcare
Live Price
Offline$28.13
+3.27% today
1Y Change
+37.70%
Window
Jun 26, 2025 β Jun 22, 2026
Coverage: 247 bars Β· Jun 26, 2025 β Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Concentra Group Holdings Parent Inc (CON) is a Healthcare stock with a market cap of $2.93B and listed on NYSE. The stock last traded around $28.13 and up 37.7% across the available one-year price window (Jun 26, 2025 β Jun 22, 2026). Baseline metrics include revenue growth of +13.9%, EPS growth of +6.9%, a dividend yield of 1.1%. What stands out right now is revenue +13.9%, EPS +6.9%, free cash flow -6.3% with operating margin 96.5% and ROIC 57.7%. The dividend is present but secondary, with a yield around 1.1%. Valuation is more restrained than many high-expectation growth names at P/E 17.4 and price/sales 1.4. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines CON price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.9% vs +7.6% peer median
Operating Margin
Above sector median
+96.5% vs +19.4% peer median
P/E
Below sector median
17.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.9% and EPS at +6.9%, with operating margin around 96.5%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.1%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +8.6% over the next 5 trading days and finished higher after 3 of those reports.
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | β | +3.4% | +13.4% | +9.2% |
2026 Jan 28, 2026 | +23.5% | +0.6% | +6.8% | +10.1% |
2025 Nov 6, 2025 | +5.4% | +3.4% | +5.6% | +4.1% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CON
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CON Max Drawdown
-21.39%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for CON and SPY.
Company Overview
Concentra Group Holdings Parent Inc
NYSE
Concentra Group Holdings Inc. is a prominent player in the healthcare and occupational health services industry. As a subsidiary of Select Medical Holdings Corporation, Concentra provides a comprehensive range of medical services, primarily focusing on occupational medicine, urgent care, and physical therapy. It serves a diverse array of clients, including employees of large corporations, small businesses, and government entities. The companyβs primary aim is to ensure workforce health and productivity by offering preventive care, injury treatment, and wellness programs. Through its extensive network of medical centers and on-site clinics, Concentra plays a crucial role in reducing workplace injuries and managing employee health, directly impacting industries that rely heavily on workforce efficiency such as manufacturing, transportation, and construction. Moreover, by delivering critical health services, the company contributes significantly to the broader healthcare ecosystem. Founded with a mission to provide convenient and effective healthcare solutions, Concentra Group Holdings Inc. continues to adapt to evolving healthcare demands, reinforcing its position as a key participant in the occupational health market.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.